GlassScriptPhysician profile
Daniel Jacob Borman
NPI 1275825002
$9,218.70
in general payments reported to CMS, 2019-2025
16 companies · $910 in 2025
The $910 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,297 · 2022: $1,100 · 2023: $4,365 · 2024: $1,547 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,572 · Travel and Lodging: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,572.22 |
| Travel and Lodging | $249.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,402.91 | 2021-2025 | Proclaim, Octrode, Eterna |
| Relievant Medsystems, INC. | $560.26 | 2023 | Intracept |
| Vertos Medical, INC. | $326.51 | 2022-2023 | Mild Device Kit |
| Spinal Simplicity, LLC | $183.99 | 2023-2024 | Ha Minuteman G3-R |
| Nalu Medical, INC. | $145.82 | 2023 | Nalu Neurostimulation System |
| Nevro Corp. | $130.77 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.76 | 2022-2024 | Relistor |
| Peerless Surgical INC. | $86.76 | 2024 | |
| Boston Scientific Corporation | $68.17 | 2025 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $56.01 | 2021-2025 | Vanta Adaptivestim |
| Spr Therapeutics, INC | $46.12 | 2022 | |
| Collegium Pharmaceutical, INC. | $23.47 | 2024 | Belbuca |
| Scilex Pharmaceuticals INC. | $22.19 | 2024 | |
| Forte Bio-Pharma LLC | $16.47 | 2023 | Prolate, Nalocet |
| Lilly USA, LLC | $15.64 | 2023 | Reyvow, Emgality |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $14.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Borman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.